6095 MedPeer,Inc. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

6095

MedPeer,Inc.

ー

JPY

(0.00%)

Oct 16, 3:30 pm JST

ー

USD

Oct 16, 2:30 am EDT

Result

PTS

outside of trading hours

ー

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Sep, 2021	7,435	1,783	1,812	1,293	60.1	0	Nov 11, 2021	J-GAAP
Sep, 2022	8,452	1,063	1,113	812	37.6	0	Nov 14, 2022	J-GAAP
Sep, 2023	14,540	1,119	1,164	617	28.3	4.50	Nov 13, 2023	J-GAAP
Sep, 2024	14,948	1,291	1,264	1,481	68.3	4.50	Nov 13, 2024	J-GAAP
Sep, 2025 Guidance	12,400	770	820	500	23.0	0	May 14, 2025	J-GAAP
YoY	-17.0%	-40.4%	-35.1%	-66.2%	-66.3%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Sep, 2020	Nov 13, 2019	4,300	800	765	500	0	J-GAAP
	Feb 13, 2020	5,200	820	800	520	0	J-GAAP
	Aug 13, 2020	5,250	1,070	1,070	650	0	J-GAAP
Results	Nov 12, 2020	5,311	1,104	1,130	725	0	J-GAAP
Sep, 2021	Nov 12, 2020	Available in future release
	Aug 12, 2021
Results	Nov 11, 2021
Sep, 2022	Nov 11, 2021
	Aug 9, 2022
Results	Nov 14, 2022
Sep, 2023	Nov 14, 2022
	Aug 9, 2023
Results	Nov 13, 2023
Sep, 2024	Nov 13, 2023
	Aug 14, 2024
Results	Nov 13, 2024
Sep, 2025	Nov 13, 2024	12,400	770	820	500	4.5	J-GAAP
	May 14, 2025	12,400	770	820	500	0	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Sep, 2009	54	－	Available in future release
Sep, 2010	74	+37.0
Sep, 2011	138	+86.5
Sep, 2012	324	+134.8
Sep, 2013	574	+77.2
Sep, 2014	958	+66.9
Sep, 2015	1,039	+8.5
Sep, 2016	973	-6.4
Sep, 2017	1,559	+60.2
Sep, 2018	2,199	+41.1
Sep, 2019	3,045	+38.5
Sep, 2020	5,311	+74.4
Sep, 2021	7,435	+40.0
Sep, 2022	8,452	+13.7
Sep, 2023	14,540	+72.0
Sep, 2024	14,948	+2.8
Sep, 2025 Guidance	12,400	-17.0	770	-40.4	820	-35.1	23.0	-66.3

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Sep, 2023	14,540	1,119	7.70	7.78	5.03	1.19	28.3
Sep, 2024	14,948	1,291	8.64	16.71	9.64	0.97	68.3
Sep, 2025 Guidance	12,400	770	6.21	5.11	3.41	0.85	23.0

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	14,948	1,783	1,812	1,481	68.3
Fiscal Year	Sep, 2024	Sep, 2021	Sep, 2021	Sep, 2024	Sep, 2024

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Apr - Sep, 2022	4,012	197	224	214	9.9	0	Nov 14, 2022	J-GAAP
Apr - Sep, 2023	7,411	403	429	237	10.9	4.50	Nov 13, 2023	J-GAAP
Apr - Sep, 2024	7,098	456	433	1,282	59.1	4.50	Nov 13, 2024	J-GAAP
Apr - Sep, 2025 Guidance	6,088	141	166	74	3.4	0	May 14, 2025	J-GAAP
YoY	-14.2%	-69.1%	-61.7%	-94.2%	-94.2%

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Sep, 2022	1,063	431	853	-422	7	6,138	65.64	J-GAAP
Sep, 2023	1,119	-4,411	600	-5,011	3,666	5,393	35.57	J-GAAP
Sep, 2024	1,291	3,156	1,890	1,266	-1,269	7,280	46.80	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Oct - Jun, 2022	10,682	824	853	408	18.7	73.3	Aug 9, 2023	J-GAAP
Oct - Jun, 2023	11,445	1,028	1,029	429	19.8	81.4	Aug 14, 2024	J-GAAP
Oct - Jun, 2024	9,068	744	700	436	20.1	85.4	Aug 14, 2025	J-GAAP
YoY	-20.8%	-27.6%	-32.0%	+1.6%	+1.6%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jul - Sep, 2023	3,858	295	311	209	9.6	7.6	Nov 13, 2023	J-GAAP
Oct - Dec, 2023	4,152	496	485	289	13.4	11.9	Feb 13, 2024	J-GAAP
Jan - Mar, 2024	3,698	339	346	-90	-4.2	9.2	May 13, 2024	J-GAAP
Apr - Jun, 2024	3,595	193	198	230	10.6	5.4	Aug 14, 2024	J-GAAP
Jul - Sep, 2024	3,503	263	235	1,052	48.5	7.5	Nov 13, 2024	J-GAAP
Oct - Dec, 2024	3,526	523	529	328	15.1	14.8	Feb 13, 2025	J-GAAP
Jan - Mar, 2025	2,786	106	125	98	4.5	3.8	May 14, 2025	J-GAAP
Apr - Jun, 2025	2,756	115	46	10	0.5	4.2	Aug 14, 2025	J-GAAP
YoY	-23.3%	-40.4%	-76.8%	-95.7%	-95.7%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Jul - Sep, 2020	1,652	+107.0	Available in future release
Oct - Dec, 2020	1,938	+106.0
Jan - Mar, 2021	1,866	+36.2
Apr - Jun, 2021	1,699	+26.0
Jul - Sep, 2021	1,932	+16.9
Oct - Dec, 2021	2,351	+21.3
Jan - Mar, 2022	2,089	+12.0
Apr - Jun, 2022	2,003	+17.9
Jul - Sep, 2022	2,009	+4.0
Oct - Dec, 2022	3,686	+56.8
Jan - Mar, 2023	3,443	+64.8
Apr - Jun, 2023	3,553	+77.4
Jul - Sep, 2023	3,858	+92.0
Oct - Dec, 2023	4,152	+12.6
Jan - Mar, 2024	3,698	+7.4
Apr - Jun, 2024	3,595	+1.2
Jul - Sep, 2024	3,503	-9.2
Oct - Dec, 2024	3,526	-15.1
Jan - Mar, 2025	2,786	-24.7
Apr - Jun, 2025	2,756	-23.3	115	-40.4	46	-76.8	0.5	-95.3

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	4,152	626	637	1,052	48.5
Fiscal Year	Dec, 2023	Dec, 2020	Dec, 2020	Sep, 2024	Sep, 2024

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Sep, 2022	350.71	81.1	9,351	7,582	3,236	0.02	Nov 14, 2022	J-GAAP
Sep, 2023	382.10	54.6	15,162	8,286	3,854	0.46	Nov 13, 2023	J-GAAP
Sep, 2024	434.74	60.7	15,554	9,442	5,238	0.33	Nov 13, 2024	J-GAAP
Oct - Jun, 2024	ー	66.8	14,658	9,791	5,577	0.28	Aug 14, 2025	J-GAAP

MedPeer,Inc.(6095) Financial Results